Postparacentesis plasma expansion prevents asymptomatic laboratory abnormalities, but does it have any impact on morbidity or mortality?
Antillon
M R
MR
Runyon
B A
BA
D000418:Albumins / Q000627:therapeutic use*; D001201:Ascites / Q000401:mortality / Q000628:therapy*; D004232:Diuretics / Q000627:therapeutic use; D004322:Drainage; D006801:Humans; D009017:Morbidity; D010952:Plasma Substitutes / Q000627:therapeutic use; D011677:Punctures
D000418:Albumins; D004232:Diuretics; D010952:Plasma Substitutes